galantamine has been researched along with citalopram in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Byrd, EH; Chismar, R; Dey, S; Holtzheimer, PE; Kelley, ME; McDonald, WM; McWhorter, K; Meeks, TW; Mufti, M; Quinn, S; Vito, N; Young, R | 1 |
| Chaly, T; Dhawan, V; Eidelberg, D; Hermann, CR; Kramer, E; Ma, Y; Smith, GS | 1 |
| Darvesh, S; Martin, E; Rockwood, K; Walsh, R | 1 |
| Klaassens, BL; Rombouts, SA; van der Grond, J; van Gerven, JM; van Gorsel, HC; Winkler, AM | 1 |
| Klaassen, ES; Klaassens, BL; Rombouts, SARB; van der Grond, J; van Gerven, JMA | 2 |
1 review(s) available for galantamine and citalopram
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for galantamine and citalopram
| Article | Year |
|---|---|
A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression.
Topics: Aged; Antidepressive Agents; Cholinesterase Inhibitors; Citalopram; Cyclohexanols; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Galantamine; Humans; Male; Middle Aged; Neuropsychological Tests; Pilot Projects; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 2008 |
Time related effects on functional brain connectivity after serotonergic and cholinergic neuromodulation.
Topics: Adolescent; Adult; Brain; Brain Mapping; Cholinergic Agents; Cholinesterase Inhibitors; Citalopram; Cross-Over Studies; Double-Blind Method; Female; Galantamine; Humans; Hydrocortisone; Image Processing, Computer-Assisted; Male; Models, Neurological; Oxygen; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin; Young Adult | 2017 |
Serotonergic and cholinergic modulation of functional brain connectivity: A comparison between young and older adults.
Topics: Adolescent; Adult; Aged; Aging; Cerebral Cortex; Cholinesterase Inhibitors; Citalopram; Connectome; Cross-Over Studies; Double-Blind Method; Female; Galantamine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Selective Serotonin Reuptake Inhibitors; Young Adult | 2018 |
Cholinergic and serotonergic modulation of resting state functional brain connectivity in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebellum; Cerebral Cortex; Cholinesterase Inhibitors; Citalopram; Connectome; Cross-Over Studies; Double-Blind Method; Female; Galantamine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Selective Serotonin Reuptake Inhibitors; Thalamus | 2019 |
7 other study(ies) available for galantamine and citalopram
| Article | Year |
|---|---|
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Area Under Curve; Biomarkers; Brain; Case-Control Studies; Cholinesterase Inhibitors; Citalopram; Drug Synergism; Female; Galantamine; Glucose; Humans; Male; Positron-Emission Tomography; Prolactin; Selective Serotonin Reuptake Inhibitors | 2009 |
Synergistic inhibition of butyrylcholinesterase by galantamine and citalopram.
Topics: Butyrylcholinesterase; Cholinesterase Inhibitors; Citalopram; Drug Synergism; Galantamine; Humans; Models, Theoretical | 2011 |